How much revenue does Claritas Pharmaceuticals make?

Claritas Pharmaceuticals reported $0 in revenue for fiscal year 2020.

What companies are similar to Claritas Pharmaceuticals?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Evelo Biosciences, Inc. (EVLO), Ventura Cannabis & Wellness Corporation (CVHIF), Anthera Pharmaceuticals, Inc. (ANTH), Sproutly Canada Inc. (SRUTF).

Claritas Pharmaceuticals, Inc. (CLAZF) Stock

About Claritas Pharmaceuticals, Inc.

Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. Claritas Pharmaceuticals, Inc. was founded in 2014 and is based in San Rafael, California.

At a glance

Claritas Pharmaceuticals reported revenue of $0 for fiscal year 2020, and net income of $4.21 million.

Figures from company filings; latest fiscal year ended December 31, 2020.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.